Lanxess buys Brazilian biocide maker, exits Currenta

3 December 2019 - 0 Submitted by Andrew Warmington

Lanxess has agreed to acquire Itibanyl Produtos Especiais (IPEL), a family-owned company based at Jarinu, São Paulo. Terms were not disclosed and the deal should be completed in Q1 2020, subject to regularly approvals.

IPEL is said to be one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018, mostly in biocides. It employs around 100 people and has both laboratory and manufacturing facilities.

This gives Lanxess’s Material Protection Products business unit a manufacturing presence on four continents, as well as access to strategic intermediate products. “IPEL also has a strong customer network that will soon be able to benefit from our combined product portfolio and regulatory expertise,” added Oliver Kretschik, head of the Biocides business line.

Separately, Lanxess has completed the sale of its 40% stake in chemical park operator and site services provider Currenta to funds managed by Australia-based Macquarie Infrastructure & Real Assets (MIRA). The former owner, Bayer, has simultaneously sold its 60% share. Lanxess’s take was given a pre-tax equity value of €780 million.

Currenta manages the chemical parks in Leverkusen, Dormagen and Krefeld-Uerdingen, Germany. The sale, which was agreed in August, came about because Bayer announced plans to exit Currenta in November 2018 and neither Lanxess nor Covestro wanted to take over any of its share.

Lanxess expects retain its share in the park operator until April next year and will give operational support to MIRA during the transitional phase while receiving a share of the profits. CEO Matthias Zachert added that the sale will give Lanxess “additional leeway to drive forward our growth course in speciality chemicals”.

Feature Article - Addressing the circular economy challenge: A perspective on BFRs

Nov 25, 2020/0

Dr Kevin Bradley, secretary general of the International Bromine Council, takes a look at how brominated flame retardant manufacturers and their associations are addressing the challenges arising from public policy and new business models driving the Circular Economy

Croda, Novasep part of key COVID vaccines

Nov 18, 2020/0

Both Croda International and Novasep are involved in some of the vaccines nearing approval for use in the treatment of COVID-19 it has emerged. This follows on from many other announcements of development agreements involving other fine chemical companies earlier in the year.

Sumitomo Chemical launches SynBio Hub

Nov 18, 2020/0

Shortly after handing over responsibility for biorational-related business to its Valent BioSciences (VBC) subsidiary in Illinois, Sumitomo Chemical has announced plans to establish SynBio Hub within its Biorational Research Centre.

Cambrex expands US API capacity

Nov 18, 2020/0

Small molecule CDMO Cambrex is spending $50 million to expand its mid- and large-scale API manufacturing capacity in Charles City, Iowa. This is the sixth major investment at the site in the past eight years and follows on from a recent, smaller expansion at the site in Karlskroga, Sweden.

Merck KGaA presents sustainability strategy

Nov 18, 2020/0

Alongside its Q3 results, Merck KGaA presented its new sustainability strategy, which it said integrates sustainability “more strongly as an essential component of its corporate strategy”. The bonus pay of board members will be linked to progress in the three specific goals, which are:

CordenPharma further expands peptides

Nov 18, 2020/0

CordenPharma is to expand non-GMP solid-phase peptide synthesis (SPPS) capacity at its centre of excellence for peptide process development and non-GMP manufacturing at Frankfurt, Germany. This should be complete in Q3 2021. The amount invested has not been disclosed.